• CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal Res

  2026-06-20

  CA-074 Me is a potent, cell-permeable cathepsin B inhibitor central to apoptosis and necroptosis research. Its high selectivity and solubility profile enable precise dissection of lysosomal pathways in cell death and inflammation models.

• CFDA SE Cell Tracer Kit: Practical Guidance for Cell Trackin

  2026-06-19

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides a robust solution for long-term, stable fluorescent cell labeling in cell proliferation and lineage tracing workflows. It is not suitable for reversible or short-term cell labeling applications, nor for experiments requiring rapid dye clearance.

• Endothelial SGK1 Drives Vascular Stiffening via Actin Remode

  2026-06-19

  Zhang et al. identify endothelial SGK1 as a mechanistic driver of vascular stiffening in salt-sensitive hypertension. Their work demonstrates that both genetic deletion and pharmacological inhibition of SGK1, notably with EMD638683, attenuate endothelial and aortic stiffness by reducing actin polymerization, providing a clear rationale for SGK1 targeting in cardiovascular research.

• CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor for O

  2026-06-18

  CHIR 99021 trihydrochloride is redefining how researchers balance stem cell self-renewal and differentiation in organoid and metabolic disease models. Its robust GSK-3 inhibition, documented at nanomolar potency, empowers reproducible modulation of insulin signaling and cellular diversity, elevating both experimental rigor and scalability.

• Mestranol-Induced Reversible Lysosomal Stress in Zebrafish M

  2026-06-18

  This study demonstrates that mestranol, a synthetic estrogen, triggers a reversible lysosomal storage–like state in zebrafish microglia without affecting apoptosis or cell number. The findings establish a live, pharmacologically inducible model for investigating how environmental estrogens disrupt microglial lysosomal function and transcriptional regulation.

• Pam3CSK4 TFA: Precision TLR1/2 Agonist for Translational Imm

  2026-06-17

  Pam3CSK4 TFA empowers researchers to dissect TLR1/2-driven cytokine responses, facilitating translational advances in maternal-neonatal immunity and biomarker discovery. Its high purity and robust activation profile make it the gold standard for both in vitro and in vivo studies of innate immune signaling.

• Advancing mRNA Delivery: Mechanistic Insight and Strategic T

  2026-06-17

  Explore how 5-methoxyuridine modified mRNA technologies, such as ARCA Cy5 EGFP mRNA (5-moUTP), are transforming translational research. The article bridges molecular rationale, experimental best practices, and the evolving landscape of mRNA delivery systems, anchoring recommendations in recent advances in nanoparticle engineering and immune modulation.

• Structure-Based Inhibitor Discovery for SARS-CoV-2 NSP15 End

  2026-06-16

  This study used structure-based virtual screening of natural products to identify potent inhibitors of the SARS-CoV-2 endoribonuclease NSP15, a key player in viral immune evasion. Thymopentin and oleuropein emerged as lead candidates, validated by molecular dynamics simulations, suggesting a new avenue for COVID-19 therapeutic development.

• Technical Workflow Guide: Cathepsin B Inhibitor CA-074 (A192

  2026-06-16

  Cathepsin B inhibitor CA-074 is designed for selective, high-affinity inhibition of cathepsin B in biochemical and cellular research. It enables researchers to interrogate cathepsin B-mediated processes such as cancer metastasis and neurotoxicity with minimal off-target interference. Use is not recommended for studies requiring broad-spectrum cysteine protease inhibition or long-term solution stability.

• EGCG Nanoparticle Radiosensitization Boosts FLASH-RT Antitum

  2026-06-15

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) markedly enhance the efficacy of ultra-high dose rate FLASH radiotherapy (FLASH-RT) by amplifying DNA double-strand breaks and promoting antitumor immunity. The approach bridges the efficacy gap between FLASH-RT and conventional radiotherapy, while maintaining biosafety, and offers a promising radiosensitization strategy for future cancer therapies.

• Caffeine as a Precision Research Tool: Mechanisms and Protoc

  2026-06-15

  Explore the role of caffeine (1,3,7-trimethylpurine-2,6-dione) as a powerful, cell-permeable probe for cancer cell line inhibition and energy metabolism modulation. This article delivers a uniquely practical, protocol-focused analysis grounded in advanced mechanistic science.

• Quizartinib (AC220): Precision FLT3 Inhibition in AML Resear

  2026-06-14

  Quizartinib (AC220) stands out as a potent and selective FLT3 inhibitor, enabling highly sensitive assays for acute myeloid leukemia (AML) research. This article dissects advanced experimental workflows, troubleshooting strategies, and the translational impact of Quizartinib in elucidating FLT3-driven oncogenic signaling.

• Fluorescein TSA Fluorescence System Kit: Mechanisms and Inno

  2026-06-13

  Explore the advanced mechanisms behind the Fluorescein TSA Fluorescence System Kit for unparalleled fluorescence detection in IHC, ICC, and ISH. This article uniquely bridges molecular amplification chemistry with real-world tissue assay challenges.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-06-12

  Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment used for precise modeling of the renin-angiotensin system in studies of blood pressure regulation and aldosterone signaling. It is suitable for focused cardiovascular and renal workflows but should be avoided in unrelated peptide signaling or outside validated RAS models. Its solubility and stability profile require careful handling and protocol adherence.

• Dantrolene Sodium Salt: Next-Gen Ryanodine Receptor Antagoni

  2026-06-12

  Explore how Dantrolene sodium salt, a potent ryanodine receptor antagonist, is transforming calcium signaling modulation in advanced research. This article reveals mechanistic insights and practical guidance unavailable elsewhere, advancing applications in genome editing, disease modeling, and synthetic lethality.

15690 records 1/1046 page Next 12345 下5页 Last page